Therapeutic Potential of ⁴⁷Sc in Comparison to ¹⁷⁷Lu and ⁹⁰Y: Preclinical Investigations

• Main Authors: Klaudia Siwowska (Author), Patrycja Guzik (Author), Katharina A. Domnanich (Author), Josep M. Monné Rodríguez (Author), Peter Bernhardt (Author), Bernard Ponsard (Author), Roger Hasler (Author), Francesca Borgna (Author), Roger Schibli (Author), Ulli Köster (Author), Nicholas P. van der Meulen (Author), Cristina Müller (Author)
• Format: Book
• Published: MDPI AG, 2019-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Targeted radionuclide therapy with ¹⁷⁷Lu- and ⁹⁰Y-labeled radioconjugates is a clinically-established treatment modality for metastasized cancer. ⁴⁷Sc is a therapeutic radionuclide that decays with a half-life of 3.35 days and emit...